InvestorsHub Logo
Followers 74
Posts 15845
Boards Moderated 0
Alias Born 04/26/2010

Re: BioChica post# 181796

Tuesday, 03/19/2019 3:30:58 PM

Tuesday, March 19, 2019 3:30:58 PM

Post# of 427151
JT has no business talking about EPA/AA ratios - he's a CPA, not a doctor - leave that to Dr. Bhatt. I think AMRN is staying away from that (yes, they measured EPA and AA in R-IT) to keep this simple for the FDA - just depend on the outcomes data to get the expanded label, don't go throwing MOA theories around until you have semi-definitive proof that the theory may be accurate. I think they're studying and analyzing ALL non-lipid biomarkers, especially inflammatory markers, to see how they correlate with outcomes, and that research is going to take time to come up with good conclusions - that data might help support JL's theory of SI being root cause of CVD. I sure hope they come up with that data, because SI is why I'm taking V - I believe it's helped me greatly, have some proof via weight loss, much less muscle pain/problems, and some blood test results, but unless I never have a CVE I won't know if V reduced my risk or not - and I was very high risk when I started taking it.

The Thought Police: To censor and protect. Craig Bruce

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News